| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |